AzTrials
AzTrials

StrokeNCT03736200

Neuro-rehabilitation Training Effects on Motion and Quality of Life After Acute Stroke and Post Stroke

A study testing Exergaming group, Physiotherapy and Exergaming group 2/day in people with Stroke, run by Somogy Megyei Kaposi Mór Teaching Hospital at 1 site in Hungary.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

High intensity motion improves motor functions and quality of life in a neurologist. The investigators want to improve the clinical condition and quality of life of post-STROKE participants with a special sensory motor and visual motor agility therapy. Read more about this study

Who is it for?
Ages 55 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Stroke
What is being tested?
Exergaming group, Physiotherapy and Exergaming group 2/day
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2 participants
Where
1 siteHungary
Study dates
1 Sep 2018to 1 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • post stroke
  • 6MWT : 120>
  • minimum after stroke 2 weeks

Who cannot join

  • Sever heart problem
  • sever demeanor
  • alcoholism
  • drug problems

Trial locations and contacts

1 site in 1 country.

Hungary1 site
  • József Tollá

    Kaposvár, Somogy County, 7400

Other trials in Hungary

About this study

High intensity motion improves motor functions and quality of life in a neurologist. The investigators want to improve the clinical condition and quality of life of post-STROKE participants with a special sensory motor and visual motor agility therapy.

Read the detailed description

High intensity motion improves engine function and quality of life in a neurologist. With special sensory motor and visual motility, investigaters want to improve the clinical condition and quality of life of STROKE participants.

The investigaters randomly select participants who only perform the rehabilitation treatment have performed. The other group that will receive the study's control group will receive the traditional rehabilitation physiotherapy treatment.

The investigaters assess the condition and quality of life of the patients. (EQ5-D, Barthel index, MRS test) The ivestigaters examine the functional movement and equilibrium variables of patients. (6MWT, Berg balance test, postgraduation) After that, participants are undergoing a 4-week intensive rehabilitation treatment. All participants are in post stroke.

Primary Hypothesis will be changes in life-quality tests (EQ5-D, Barthel index, MRS test). Functional tests show progress 6MWT, Berg balance test and postural control testing with posturography. The results are compared and evaluated among the groups.

The expected hypothesis is that visual and acoustic stimulation produces a better physical state at higher intensity.

Conditions
Stroke
Being tested
Exergaming group, Physiotherapy, Exergaming group 2/day
Keywords
balance, movement, exergaming, posture, quality of life, gait
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exergaming groupOther

    Also called EXE group

    Neurorehabilitation - 4-week-long intervention, targeted postural instability and mobility using at-limit intensity sensori and visuomotor agility training. (1/day)

  • PhysiotherapyOther

    Also called Physio group

    Physiotherapy 4-week-long.

  • Exergaming group 2/dayOther

    Also called EXE2 group

    Neurorehabilitation - 4-week-long intervention, targeted postural instability and mobility using at-limit intensity sensori and visuomotor agility training. (2/day)

Study groups in NCT03736200
Study groupRoleWhat they receive
Exergaming 1/dayActive comparatorPost stroke group that received 4 weeks of intensive therapy. (1/day)
Receives: Other: Exergaming group
physiotherapyActive comparatorPost stroke group that received 4 weeks of traditional physiotherapy.
Receives: Other: Physiotherapy
Exergaming 2/dayActive comparatorPost stroke group that received 4 weeks of intensive therapy. (2/day)
Receives: Other: Exergaming group 2/day

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of life measured by Barthel index

    questionnaire

    Measured: 4 weeks

  2. gait / functional test

    6 minute walk test (m)

    Measured: 4 weeks

  3. balance test

    Berg balance test

    Measured: 4 weeks

  4. postrural control test

    posturography (mm)

    Measured: 4 weeks

  5. Quality of life measured by EQ5-D scale

    questionnaire

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2018
  2. Study start1 Sep 2018
  3. Primary completion1 Nov 2019
  4. Study completion1 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03736200
Sponsor's protocol ID
IKEB008/2018
Status last verified
Sep 2018
First submitted
1 Nov 2018
Last updated
28 Apr 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Tollar J, Nagy F, Csutoras B, Prontvai N, Nagy Z, Torok K, Blenyesi E, Vajda Z, Farkas D, Toth BE, Repa I, Moizs M, Sipos D, Kedves A, Kovacs A, Hortobagyi T. High Frequency and Intensity Rehabilitation in 641 Subacute Ischemic Stroke Patients. Arch Phys Med Rehabil. 2021 Jan;102(1):9-18. doi: 10.1016/j.apmr.2020.07.012. Epub 2020 Aug 27.

    PubMed 32861668

Questions about this trial

What is this clinical trial studying?

A study testing Exergaming group, Physiotherapy and Exergaming group 2/day in people with Stroke, run by Somogy Megyei Kaposi Mór Teaching Hospital at 1 site in Hungary.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hungary. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of life measured by Barthel index (time frame: 4 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03736200, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in